These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9873611)

  • 1. Synthesis and biological activity of novel thiazolidinediones.
    Prabhakar C; Madhusudhan G; Sahadev K; Reddy CM; Sarma MR; Reddy GO; Chakrabarti R; Rao CS; Kumar TD; Rajagopalan R
    Bioorg Med Chem Lett; 1998 Oct; 8(19):2725-30. PubMed ID: 9873611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel benzoxazole 2,4-thiazolidinediones as potent hypoglycemic agents. Synthesis and structure-activity relationships.
    Arakawa K; Inamasu M; Matsumoto M; Okumura K; Yasuda K; Akatsuka H; Kawanami S; Watanabe A; Homma K; Saiga Y; Ozeki M; Iijima I
    Chem Pharm Bull (Tokyo); 1997 Dec; 45(12):1984-93. PubMed ID: 9433768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel phthalazinone and benzoxazinone containing thiazolidinediones as antidiabetic and hypolipidemic agents.
    Madhavan GR; Chakrabarti R; Kumar SK; Misra P; Mamidi RN; Balraju V; Kasiram K; Babu RK; Suresh J; Lohray BB; Lohrayb VB; Iqbal J; Rajagopalan R
    Eur J Med Chem; 2001; 36(7-8):627-37. PubMed ID: 11600232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Studies on compounds with antioxidant activity--development of hypoglycemic agents, troglitazone (CS-045)].
    Yoshioka T; Fujita T
    Yakugaku Zasshi; 1997 Sep; 117(9):597-610. PubMed ID: 9357328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on hindered phenols and analogues. V. Synthesis, identification, and antidiabetic activity of the glucuronide of CS-045.
    Yoshioka T; Aizawa Y; Fujita T; Nakamura K; Sasahara K; Kuwano H; Kinoshita T; Horikoshi H
    Chem Pharm Bull (Tokyo); 1991 Aug; 39(8):2124-5. PubMed ID: 1797433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel antidiabetic and hypolipidemic agents. 5. Hydroxyl versus benzyloxy containing chroman derivatives.
    Reddy KA; Lohray BB; Bhushan V; Reddy AS; Rao Mamidi NV; Reddy PP; Saibaba V; Reddy NJ; Suryaprakash A; Misra P; Vikramadithyan RK; Rajagopalan R
    J Med Chem; 1999 Aug; 42(17):3265-78. PubMed ID: 10464013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological activity of novel pyrimidinone containing thiazolidinedione derivatives.
    Madhavan GR; Chakrabarti R; Vikramadithyan RK; Mamidi RN; Balraju V; Rajesh BM; Misra P; Kumar SK; Lohray BB; Lohray VB; Rajagopalan R
    Bioorg Med Chem; 2002 Aug; 10(8):2671-80. PubMed ID: 12057656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Troglitazone prevents hyperglycemia-induced but not glucosamine-induced insulin resistance.
    Miles PD; Higo K; Romeo OM; Lee MK; Rafaat K; Olefsky JM
    Diabetes; 1998 Mar; 47(3):395-400. PubMed ID: 9519745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thiazolidinediones and their effects on glucose transporters.
    Ciaraldi T; Henry RR
    Eur J Endocrinol; 1997 Dec; 137(6):610-2. PubMed ID: 9437223
    [No Abstract]   [Full Text] [Related]  

  • 10. Troglitazone corrects metabolic changes but not vascular dysfunction in dietary-obese rats.
    Naderali EK; Pickavance LC; Wilding JP; Doyle PJ; Williams G
    Eur J Pharmacol; 2001 Mar; 416(1-2):133-9. PubMed ID: 11282122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential block by troglitazone and rosiglitazone of glibenclamide-sensitive K(+) current in rat aorta myocytes.
    Mishra SK; Aaronson PI
    Eur J Pharmacol; 1999 Dec; 386(1):121-5. PubMed ID: 10611472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of troglitazone on dexamethasone-induced insulin resistance in rats.
    Okumura S; Takeda N; Takami K; Yoshino K; Hattori J; Nakashima K; Sugimoto M; Ishimori M; Takami R; Yasuda K
    Metabolism; 1998 Mar; 47(3):351-4. PubMed ID: 9500576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TNF-alpha-induced insulin resistance in vivo and its prevention by troglitazone.
    Miles PD; Romeo OM; Higo K; Cohen A; Rafaat K; Olefsky JM
    Diabetes; 1997 Nov; 46(11):1678-83. PubMed ID: 9356012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic effects of troglitazone in the Goto-Kakizaki rat, a non-obese and normolipidemic rodent model of non-insulin-dependent diabetes mellitus.
    O'Rourke CM; Davis JA; Saltiel AR; Cornicelli JA
    Metabolism; 1997 Feb; 46(2):192-8. PubMed ID: 9030828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of the effects of troglitazone on insulin sensitivity and beta-cell function in Watanabe heritable hyperlipidemic rabbits: a minimal model analysis.
    Zhang B; Saku K; Arakawa K
    Metabolism; 1997 Mar; 46(3):273-81. PubMed ID: 9054469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Troglitazone (CS-045) on insulin secretion in isolated rat pancreatic islets and HIT cells: an insulinotropic mechanism distinct from glibenclamide.
    Masuda K; Okamoto Y; Tsuura Y; Kato S; Miura T; Tsuda K; Horikoshi H; Ishida H; Seino Y
    Diabetologia; 1995 Jan; 38(1):24-30. PubMed ID: 7744225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel euglycemic and hypolipidemic agents: Part-2. Antioxidant moiety as structural motif.
    Reddy KA; Lohray BB; Bhushan V; Reddy AS; Kishore PH; Rao VV; Saibaba V; Bajji AC; Rajesh BM; Reddy KV; Chakrabarti R; Rajagopalan R
    Bioorg Med Chem Lett; 1998 May; 8(9):999-1002. PubMed ID: 9871696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A short synthesis of troglitazone: an antidiabetic drug for treating insulin resistance.
    Cossy J; Menciu C; Rakotoarisoa H; Kahn PH; Desmurs JR
    Bioorg Med Chem Lett; 1999 Dec; 9(24):3439-40. PubMed ID: 10617087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Troglitazone inhibits fatty acid oxidation and esterification, and gluconeogenesis in isolated hepatocytes from starved rats.
    Fulgencio JP; Kohl C; Girard J; Pégorier JP
    Diabetes; 1996 Nov; 45(11):1556-62. PubMed ID: 8866561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of troglitazone and D-chiroinositol on glucosamine-induced insulin resistance in vivo in rats.
    Yoshino K; Takeda N; Sugimoto M; Nakashima K; Okumura S; Hattori J; Sasaki A; Kawachi S; Takami K; Takami R; Yasuda K
    Metabolism; 1999 Nov; 48(11):1418-23. PubMed ID: 10582551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.